When political agendas try to reshape science, integrity is the first casualty.
Assigning the power to “correct” scientific information to political appointees is not the way forward.
doi.org/10.1192/bjp.2025.103…
#ScienceIntegrity #ScientificFreedom #ResearchEthics #OpenScience
Please read this important Editorial from BJPsych, written by 22 Journal Editors of Scientific Psychiatic Journals.
doi.org/10.1192/bjp.2025.94
@scnpjournal
#MentalHealthResearch
#ScienceIntegrity
#AcademicFreedom
#MentalHealthPolicy
#ScientificTruth
Gregers Wegener retweeted
Another one on GLP-1 receptor agonists (GLP-1RA)— Could they be a new avenue for alcohol use disorder (AUD) treatment? 🍷🚫
This recent review explored the GLP-1RAs potential (as liraglutide/semaglutide) in modulating alcohol-related behaviors in preclinical and clinical studies
Gregers Wegener retweeted
Looking for a home to your paper on #Psychopharmacology or #Immunopsychiatry?
Look no further!
Final submissions are due February 1st on the Journal submission site. Check the guide for authors on:
cambridge.org/core/journals/…
Gregers Wegener retweeted
🌟Neuropsychiatric disorders 🧠 are frequently associated with metabolic comorbidities. The contributions of our most recent Special Issue present a diverse array of studies that illustrate the breadth of Metabolic Neuropsychiatry.
Check it out 🧵: cambridge.org/core/journals/…
Gregers Wegener retweeted
This new study from Dr. Harkin’s group aimed to investigate mRNA expression of the kynurenine pathway (KP) enzymes in medicated patients with depression and healthy controls, and in patients with depression after electroconvulsive therapy (ECT). 🧬🧠
doi.org/10.1017/neu.2024.34
Gregers Wegener retweeted
We are pleased to introduce the 1st special issue of Acta Neuropsychiatrica, which is dedicated to exploring the role of #cannabinoids in #psychiatric research and treatment.
cambridge.org/.../5689042CA8…...
Gregers Wegener retweeted
Just out now!!
In this double-blind randomized withdrawal trial, McIntyre et al didn't observed differences of adjunctive brexpiprazole in time to relapse, but the association was superior to placebo at other endpoints (check the paper to discover which ones).
Gregers Wegener retweeted
Today, September 23th, Editor-in-chief will be at the ECNP plaza to share more about the journal and to advise you on the publishing process and discuss the scope of Acta Neuropsychiatrica.
#neuropsychopharmacology
#Neuroscience
#Research
#ecnp – at Milan, Lombardy
Gregers Wegener retweeted
Feel free to check out our new paper written by my colleague Anna Gannedahl showing an impact of socioeconomic status on depression care in a sample of over 100 000 patients.
pubmed.ncbi.nlm.nih.gov/3891…
Gregers Wegener retweeted
We will go fully OA in 2025 but we will keep all efforts to removing publishing barriers.
Acta Neuropsychiatrica welcomes research papers from around the globe and will continue to foster inclusive #openscience.
Access the website for more info: cambridge.org/core/journals/…
Gregers Wegener retweeted
New journal @scnpjournal - Acta Neuropsychiatrica - joins the NPRC!
Read more about us and our participating journals at nprc.incf.org
#neuroscience #neuroinformatics
Gregers Wegener retweeted
⭐️ Big News: Acta Neuropsychiatrica’s CiteScore Soars to 8.5! 🏆 Ranked 10th in #Neuroscience (51 journals) & 66th in #Psychiatry (567 journals). 📊 Our CiteScore reflects the high-impact work of our authors & community trust.
Gregers Wegener retweeted
After this week's debates on #PTSD and in recognition of #DDay, we share this recent paper by @RachelYehuda group. The study found harassment during deployment correlated w/ higher suicidal ideation and lower testosterone levels. Read more: cambridge.org/core/journals/… #MentalHealth
Gregers Wegener retweeted
In light of the FDA discussion on MDMA therapy for PTSD, did you know the psychostimulant response is mediated by the endocannabinoid system?
Check this paper of @PedroGobira et al. on Acta Neuropsychiatrica
cambridge.org/core/journals/…
#MDMA #psychostimulant #FDA #MentalHealth
Gregers Wegener retweeted
📢 Exciting News: Acta Neuropsychiatrica joins the Neuroscience Peer Review Consortium (NPRC)!
cambridge.org/core/journals/…
#NPRC
#NeuroscienceCollaboration
#PeerReview
#NeuroscienceResearch
#ScientificPublishing
#MEDLINEJournals
#ResearchExcellence
#Academicchatter
Gregers Wegener retweeted
SCNP 62nd Annual Congress live!
Winner of the 'Young Scientists Symposium' announced.
We are pleased to award the 2024 prize to Eleonora Genovese for her talk.
@scnporg
@goteborgsuni
@tnu_au_dk
#SCNP2024 #SCNP #research – at Gothenburg, Sweden
Gregers Wegener retweeted
🧠 OUT IN ACTA! Toffanin et al. investigated the effects of ECT on brain cortical thickness in major depression.
🔍 Discover the regions that exhibit the most pronounced increases in cortical thickness
cambridge.org/core/journals/…
Gregers Wegener retweeted
On #StrokeAwarenessDay, let's explore the changes in affective temperaments on stroke survivors.
🔍 Researchers aimed to uncover the dominant affective temperament after stroke and explore their connection to the disability level.
Gregers Wegener retweeted
📣 Calling all Early Career Scientists in Europe! The ECNP Workshop is your chance to meet the research leaders and discuss advances in #BrainDisorders and treatments!
📍 Nice, France
📅14-17 March 2024
Apply by 26 October 👉ecnp.eu/workshop
#neuroscience #ECNP #training
